Followers | 65 |
Posts | 7115 |
Boards Moderated | 0 |
Alias Born | 06/01/2016 |

Friday, January 12, 2024 8:14:21 AM
Recent C News
- Form 424B2 - Prospectus [Rule 424(b)(2)] • Edgar (US Regulatory) • 07/11/2025 04:59:18 PM
- Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses • Edgar (US Regulatory) • 07/11/2025 03:49:12 PM
- Form 424B2 - Prospectus [Rule 424(b)(2)] • Edgar (US Regulatory) • 07/11/2025 03:18:06 PM
- Form 424B2 - Prospectus [Rule 424(b)(2)] • Edgar (US Regulatory) • 07/10/2025 09:27:30 PM
- Form 424B2 - Prospectus [Rule 424(b)(2)] • Edgar (US Regulatory) • 07/10/2025 09:20:49 PM
- Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses • Edgar (US Regulatory) • 07/10/2025 09:07:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/10/2025 08:55:20 PM
- Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses • Edgar (US Regulatory) • 07/10/2025 08:42:04 PM
- Form 424B2 - Prospectus [Rule 424(b)(2)] • Edgar (US Regulatory) • 07/10/2025 08:41:32 PM
- Form 424B2 - Prospectus [Rule 424(b)(2)] • Edgar (US Regulatory) • 07/10/2025 07:08:39 PM
- Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses • Edgar (US Regulatory) • 07/10/2025 06:16:51 PM
- Form 424B2 - Prospectus [Rule 424(b)(2)] • Edgar (US Regulatory) • 07/10/2025 03:36:13 PM
- Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses • Edgar (US Regulatory) • 07/10/2025 01:50:19 PM
- Form 424B2 - Prospectus [Rule 424(b)(2)] • Edgar (US Regulatory) • 07/10/2025 01:37:09 PM
- Citigroup annuncia il rimborso di 1,75 miliardi di euro in obbligazioni a tasso fisso/variabile al 1,500%, con scadenza 2026 • Business Wire • 07/09/2025 06:56:00 PM
- Citigroup annonce le remboursement de 1,75 milliard d'euros d'obligations à taux fixe/variable de 1,500 % à échéance 2026 • Business Wire • 07/09/2025 06:56:00 PM
- Citigroup gibt Rückzahlung von festverzinslichen/variabel verzinslichen Schuldverschreibungen im Wert von 1,75 Mrd. EUR mit Fälligkeit 2026 bekannt • Business Wire • 07/09/2025 06:55:00 PM
- Form 424B2 - Prospectus [Rule 424(b)(2)] • Edgar (US Regulatory) • 07/09/2025 04:38:03 PM
- Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses • Edgar (US Regulatory) • 07/09/2025 04:02:40 PM
- Citi Appointed as Depositary Bank for Scage Future’s ADR Program • Business Wire • 07/09/2025 01:30:00 PM
- Form 424B2 - Prospectus [Rule 424(b)(2)] • Edgar (US Regulatory) • 07/09/2025 01:16:11 PM
- Form 424B2 - Prospectus [Rule 424(b)(2)] • Edgar (US Regulatory) • 07/09/2025 01:13:14 PM
- Citigroup Announces €1.75 Billion Redemption of 1.500% Fixed Rate/Floating Rate Notes Due 2026 • Business Wire • 07/09/2025 12:30:00 PM
- Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses • Edgar (US Regulatory) • 07/09/2025 11:46:48 AM
- Form 424B2 - Prospectus [Rule 424(b)(2)] • Edgar (US Regulatory) • 07/08/2025 09:24:09 PM
Glidelogic Corp. Announces Release of First AI-Generated Novel "The Thirteenth Proposal" • GDLG • Jul 11, 2025 12:20 PM
Fifty1 AI Labs' REVIVE Clinical Trial Redefines Long COVID Treatment, Pioneering AI-Driven Therapies and Propelling Fifty 1 Labs, Inc. Toward $50M Valuation and Global Biotech Leadership • FITY • Jul 10, 2025 8:30 AM
Aspire Biopharma Holdings, Inc., Announces Positive Consumer Feedback from Company Sampling of BUZZ BOMB™, its New Sublingual Pre-Workout Supplement • ASBP • Jul 9, 2025 9:15 AM
Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers • IBRX • Jul 9, 2025 9:00 AM
Fifty 1 Labs, Inc. Announces Bold Expansion Plan Powered by Nobel Prize Laureate Management Team, Cutting-Edge AI Healthcare Innovation and $350K Leadership Investment • FITY • Jul 8, 2025 8:30 AM
Avant Technologies and Partner, Ainnova, Launch Transformative Preventative Care Model for Chronic Patients Across Latin America • AVAI • Jul 8, 2025 8:00 AM